Hinge Therapeutics logo — Hinge Therapeutics is an early-stage biopharmaceutical compa...

Hinge Therapeutics

Hinge Therapeutics is an early-stage biopharmaceutical company which focuses on developing therapies for unmet needs.

Founded 2017 United States Torrance, United States 4 employees Biotechnology, Health Care

General Information

Company Name Hinge Therapeutics
Founded Year 2017
Location United States Torrance, United States +1
Employees 4
Industries Biotechnology, Health Care
Social

Get notified when Hinge Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Hinge Therapeutics

Hinge Therapeutics is an early-stage biopharmaceutical company based in Torrance, CA (main lab) and in Sunnyvale, CA (satellite lab). Their focus is on developing small-molecule and small peptide therapeutics against traditionally undruggable/challenging targets for unmet medical needs. The company's proprietary Hinge Drug Discovery Platform has generated several novel inactivators against targets traditionally targeted only by large molecules such as antibody and siRNA, or not targeted by any means. Hinge Therapeutics is working on targets in bleeding disorders (including Hemophilia A&B), immuno-oncology (immuno-suppression), solid tumors (targeting tumor microenvironment), and Alzheimer’s. Additionally, they are developing a proprietary multi-ion bioimager which enables functional measurement of their targets in real-time. Their integrated drug discovery platform enables fast drug design and validation against some of the most challenging targets and diseases in the biotechnology and healthcare industries. The company was founded in 2017. Currently, there is no available information about their last investment or the investors involved.

Taxonomy: biopharmaceuticals, drug discovery, rare diseases, CNS disorders, oncology, bleeding disorders, undruggable targets, protein conformation, small-molecule therapeutics, peptide therapeutics, immuno-oncology, tumor microenvironment, Alzheimer's, functional measurement, biomarker imaging

No funding data available for Hinge Therapeutics yet.

Get notified when Hinge Therapeutics raises funding

Hinge Therapeutics Alternatives & Competitors

Hinge Therapeutics vs
iBio, Inc.
iBio, Inc. United States

AI-Powered Precision Antibody Therapeutics

Post Ipo Equity
50 employees
Biotechnology, Robotics
Hinge Therapeutics vs
Menten AI
Menten AI United States

Unlocking the potential of peptides macrocycles to create tomorrow's life-changing medicines with Ge...

Seed
19 employees
AI, Biotechnology
Hinge Therapeutics vs

Advancing precision therapeutics for challenging pharmaceutical targets through pioneering technolog...

Series B
11-50 employees
Biotechnology, Health Care

FAQ About Hinge Therapeutics

Hinge Therapeutics is an early-stage biopharmaceutical company which focuses on developing therapies for unmet needs.
Hinge Therapeutics was founded in 2017.
Hinge Therapeutics is headquartered in Torrance, United States.
Hinge Therapeutics operates in the following industries: Biotechnology, Health Care.
Hinge Therapeutics has approximately 4 employees.
Top alternatives and competitors to Hinge Therapeutics include iBio, Inc., Menten AI, Exo Therapeutics, PharmEnable Therapeutics, Immuto Scientific. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Hinge Therapeutics and iBio, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Hinge Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy